Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the closing of an oversubscribed $225 million Series B financing round. The syndicate wasled by General…
Catalent Affirms Commitment to Customers and Patients Amidst Novo Holdings Acquisition Alessandro Maselli to Remain President and CEO of Catalent Post-Acquisition Catalent, Inc. (NYSE: CTLT), a leader in the development and supply of innovative treatments for patients worldwide, has released…
bioAffinity Technologies Announces $2.66 Million Registered Direct Offering and Concurrent Private Placement bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company dedicated to developing noninvasive tests for early-stage cancer detection, has entered into a securities purchase agreement with institutional investors.…
Biological Lattice Industries Corp. (BLI), an innovator in biofabrication and life sciences, has closed a $1.8 million pre-seed funding round led by Greek venture capital firm Uni.Fund. Alongside this investment, BLI is launching its first integrated biofabrication solution: BioLoom™, a…
Trinity Life Sciences has introduced a new Omnichannel Reporting Suite, offering key promotional activity insights for stakeholders in the life sciences industry. The suite aims to address a significant gap, as 32% of life science marketing and analytics teams report…
Audax Private Equity has acquired the clinical services division of Avantor, Inc. and rebranded it as Resonant Clinical Solutions (“Resonant”). Resonant comprises three established brands: EPL Archives, MESM, and Therapak, which have roots dating back to the 1970s. These brands…
The “High Potency APIs (HPAPIs) – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offerings. The global HPAPIs market was valued at $26.3 billion in 2023 and is projected to reach $46.9 billion by 2030, growing at a CAGR…
bioAffinity Technologies Announces $2.66 Million Offering with Concurrent Private Placement bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology firm dedicated to noninvasive cancer detection, has entered into a securities purchase agreement with institutional investors for the sale of 2,048,294 shares…
New Report: COPD Drug Market Analysis and Forecast (2024-2033) ResearchAndMarkets.com has released the report “COPD: Seven-Market Drug Forecast and Market Analysis,” detailing the COPD drug market across seven major regions: the US, France, Germany, Italy, Spain, the UK, and Japan…
Biological Lattice Industries Secures $1.8 Million Pre-Seed Funding to Democratize Biofabrication Biological Lattice Industries Corp. (BLI), an innovator in biofabrication and life sciences research and development, has successfully closed a $1.8 million pre-seed investment round led by the Greek venture…
SullivanCotter Reports on Rising Healthcare Executive Compensation Amid Talent Competition SullivanCotter, a leading consulting firm specializing in total rewards programs and workforce solutions for healthcare, has published its 2024 Health Care Management and Executive Compensation Survey. This comprehensive report includes…
Personalized Nutrition Market Report 2024: Overview and Growth Projections The report titled “Personalized Nutrition Market – Types, Forms, Applications and End-Use Markets” has been released by ResearchAndMarkets.com. The global personalized nutrition market is expected to grow from an estimated $14.7…